TFF Pharmaceuticals, Inc.

NasdaqCM:TFFP Stock Report

Market Cap: US$6.5m

TFF Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

TFF Pharmaceuticals has a total shareholder equity of $9.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $12.0M and $2.5M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$5.48m
EquityUS$9.57m
Total liabilitiesUS$2.46m
Total assetsUS$12.03m

Recent financial health updates

Recent updates

Can TFF Pharmaceuticals (NASDAQ:TFFP) Afford To Invest In Growth?

Apr 10
Can TFF Pharmaceuticals (NASDAQ:TFFP) Afford To Invest In Growth?

Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?

Sep 27
Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?

TFF Pharma: The Potential Is Still Very Much Present

Aug 29

TFF Pharmaceuticals: Q3 Data Is Pivotal In So Many Ways

Aug 09

TFF Pharmaceuticals expands R&D operations with new Austin facility

Jul 14

TFF Pharmaceuticals: A Highly Attractive Basket Of Options

May 23

We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully

May 17
We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully

Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation

Jan 06
Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation

TFF Pharmaceuticals: Upside Catalysts Starting To Show Up Amid Omicron, But Timidly

Dec 02

Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

Sep 16
Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

TFF Pharmaceuticals: Cautiously Optimistic

Sep 09

TFF Pharma's Platform Is Highly Relevant In The Battle Against The Pandemic

Jul 27

TFF Pharmaceuticals: Looking Attractive At These Prices

Jun 03

Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

Mar 30
Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

Financial Position Analysis

Short Term Liabilities: TFFP's short term assets ($7.6M) exceed its short term liabilities ($2.4M).

Long Term Liabilities: TFFP's short term assets ($7.6M) exceed its long term liabilities ($31.7K).


Debt to Equity History and Analysis

Debt Level: TFFP is debt free.

Reducing Debt: TFFP has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TFFP has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: TFFP is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.